Literature DB >> 3081188

A defence of the small clinical trial: evaluation of three gastroenterological studies.

J Powell-Tuck, K D MacRae, M J Healy, J E Lennard-Jones, R A Parkins.   

Abstract

Mesh：

Substances：

Year:  1986        PMID： 3081188      PMCID： PMC1339576          DOI： 10.1136/bmj.292.6520.599

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  16 in total

1.  COMPARISON OF ORAL AND RECTAL STEROIDS IN THE TREATMENT OF PROCTOCOLITIS.

Authors:  J J MISIEWICZ; J E LENNARD-JONES; F A JONES
Journal:  Proc R Soc Med       Date:  1964-07

2.  The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials.

Authors:  J A Freiman; T C Chalmers; H Smith; R R Kuebler
Journal:  N Engl J Med       Date:  1978-09-28       Impact factor: 91.245

3.  Explanatory and pragmatic attitudes in therapeutical trials.

Authors:  D Schwartz; J Lellouch
Journal:  J Chronic Dis       Date:  1967-08

4.  Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid enemas.

Authors:  M Campieri; G A Lanfranchi; G Bazzocchi; C Brignola; F Sarti; G Franzin; A Battocchia; G Labo; P R Dal Monte
Journal:  Lancet       Date:  1981-08-08       Impact factor: 79.321

5.  Sensibility of the rectum to distension and the anorectal distension reflex in ulcerative colitis.

Authors:  M J Farthing; J E Lennard-jones
Journal:  Gut       Date:  1978-01       Impact factor: 23.059

6.  Colonic motility in the irritable bowel syndrome.

Authors:  T W Burns
Journal:  Arch Intern Med       Date:  1980-02

7.  Plasma prednisolone levels after administration of prednisolone-21-phosphate as a retention enema in colitis.

Authors:  J Powell-Tuck; J E Lennard-Jones; C S May; C G Wilson; J W Paterson
Journal:  Br Med J       Date:  1976-01-24

8.  Clinical and manometric effects of nifedipine in patients with esophageal achalasia.

Authors:  M Bortolotti; G Labò
Journal:  Gastroenterology       Date:  1981-01       Impact factor: 22.682

9.  Effect of nifedipine on oesophageal motility and gastric emptying.

Authors:  J N Blackwell; S Holt; R C Heading
Journal:  Digestion       Date:  1981       Impact factor: 3.216

10.  An experiment to determine the active therapeutic moiety of sulphasalazine.

Authors:  A K Azad Khan; J Piris; S C Truelove
Journal:  Lancet       Date:  1977-10-29       Impact factor: 79.321
View more
  9 in total

1.  Meta-analysis of the placebo response in ulcerative colitis.

Authors:  Sagar Garud; Alphonso Brown; Adam Cheifetz; Emily B Levitan; Ciaran P Kelly
Journal:  Dig Dis Sci       Date:  2007-10-13       Impact factor: 3.199

2.  Role of 5-aminosalicylic acid (5-ASA) in treatment of inflammatory bowel disease: a systematic review.

Authors:  Javier P Gisbert; Fernando Gomollón; José Maté; José María Pajares
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

3.  The small clinical trial: is there a better way?

Authors:  R J Prescott
Journal:  Thorax       Date:  1986-11       Impact factor: 9.139

4.  Pouch versus esophagojejunostomy after total gastrectomy: a randomized clinical trial.

Authors:  H Troidl; J Kusche; K H Vestweber; E Eypasch; U Maul
Journal:  World J Surg       Date:  1987-12       Impact factor: 3.352

5.  Optimum dosage of 5-aminosalicylic acid as rectal enemas in patients with active ulcerative colitis.

Authors:  M Campieri; P Gionchetti; A Belluzzi; C Brignola; M Tampieri; P Iannone; M Miglioli; L Barbara
Journal:  Gut       Date:  1991-08       Impact factor: 23.059

Review 6.  The irritable bowel syndrome.

Authors:  S M Collins
Journal:  CMAJ       Date:  1988-02-15       Impact factor: 8.262

7.  What dose of 5-aminosalicylic acid (mesalazine) in ulcerative colitis?

Authors:  S A Riley
Journal:  Gut       Date:  1998-06       Impact factor: 23.059

Review 8.  Mesalazine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in chronic inflammatory bowel disease.

Authors:  R N Brogden; E M Sorkin
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

9.  The reporting of p values, confidence intervals and statistical significance in Preventive Veterinary Medicine (1997-2017).

Authors:  Locksley L McV Messam; Hsin-Yi Weng; Nicole W Y Rosenberger; Zhi Hao Tan; Stephanie D M Payet; Mahishi Santbakshsing
Journal:  PeerJ       Date:  2021-11-24       Impact factor: 2.984
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.